Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
BörsenkürzelARAY
Name des UnternehmensAccuray Inc
IPO-datumFeb 08, 2007
CEOMs. Suzanne C. Winter
Anzahl der mitarbeiter987
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 08
Addresse1240 Deming Way
StadtMADISON
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl53717
Telefon16088242800
Websitehttps://www.accuray.com/
BörsenkürzelARAY
IPO-datumFeb 08, 2007
CEOMs. Suzanne C. Winter
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten